DR AGARWALS EYE HOSPITAL
|
|
BOM : 526783     NSE :      | |
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive] Debt : Average |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Upward Pledged Shares : Average [>25% and <50%] |
Dec 13,2024 |
Price(EOD): ₹ 5,605.00
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Hospital & Healthcare Services |
MCap: ₹ 2,634.35 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
DR AGARWALS EYE HOSPITAL | -0.3% | 8.6% | 99.5% |
APOLLO HOSPITALS ENTERPRISE | 0.9% | 3.5% | 30.3% |
MAX HEALTHCARE INSTITUTE | 5.7% | 14.4% | 70% |
GLOBAL HEALTH | -5.5% | 5.1% | 18.9% |
FORTIS HEALTHCARE | -1.2% | 10.6% | 86.7% |
NARAYANA HRUDAYALAYA | -3% | 0.5% | 10.5% |
ASTER DM HEALTHCARE | -2.2% | 9.7% | 20.7% |
DR LAL PATHLABS | -4.4% | -0.9% | 18.8% |
KRISHNA INSTITUTE OF MEDICAL SCIENCES | -4.8% | 6.5% | 57.8% |
FUNDAMENTAL ANALYSIS OF DR AGARWALS EYE HOSPITAL
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF DR AGARWALS EYE HOSPITAL
 Ratio | Standalone | |
---|---|---|
P/E P/B P/S |
52.18
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 50.49 Cr
[Latest Qtr - Sep2024 - Standalone Results ] 16.76
P/B Calculated based on Book Value of Rs 157.15 Cr
[Latest Year - Mar2024 - Standalone Results ] 7.35
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 0.00 Cr
[Latest Qtr - Sep2024 - Standalone Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
419% 611% 647% |
SHARE PRICE MOMENTUM OF DR AGARWALS EYE HOSPITAL
DR AGARWALS EYE HOSPITAL vs SENSEX
DEBT OF DR AGARWALS EYE HOSPITAL
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2024 2023 2022 Avg_3yrs |
0.33 0.39 0.41 0.38 |
- - - - |
[Last Annual Data : Mar2024]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF DR AGARWALS EYE HOSPITAL
Pledged Promoter Shares |
39.95 % | |
---|---|---|
As on : Dec2023 | ||
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF DR AGARWALS EYE HOSPITAL
Standalone | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
2.17% -4.87% 1.16% 0.28% |
21.52% 28.74% 14.89% 12.39% |
QtrlyTrend |
6 | |
Latest Qtr: Sep2024 | ||
Quarterly Result Analysis → |
DR AGARWALS EYE HOSPITAL related INDICES
You may also like the below Video Courses
FAQ about DR AGARWALS EYE HOSPITAL
Is DR AGARWALS EYE HOSPITAL good for long term investment?
As on Dec 13,2024, the Fundamentals of DR AGARWALS EYE HOSPITAL look Strong and hence it may be good for long term investment! See Financial Performance of DR AGARWALS EYE HOSPITAL . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is DR AGARWALS EYE HOSPITAL UnderValued or OverValued?
As on Dec 13,2024, DR AGARWALS EYE HOSPITAL is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of DR AGARWALS EYE HOSPITAL ?
As on Dec 13,2024, the Intrinsic Value of DR AGARWALS EYE HOSPITAL is Rs. 788.58 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 1,079.04
Fair Value [Median EV / Sales Model] : Rs. 788.58
Fair Value [Median Price / Sales Model] : Rs. 750.21
Estimated Median Fair Value of DR AGARWALS EYE HOSPITAL : Rs. 788.58
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.